Charlotte Coe, a State Department IT specialist, spent eight years on hormone replacement therapy and six years undergoing surgeries — vaginoplasty, breast augmentation and revision, facial feminization, orchiectomy — all covered by federal employee insurance. The result, according to Coe's own sworn declaration: a lesion in the urethral tissue that repeatedly reopens, described as feeling "like a constant papercut," and a condition that makes "sexual activity of any kind painful and dangerous" due to near-constant infection risk.
That's the care the government told its own workers was medically necessary.
Coe is one of three named class representatives in a putative class action filed in Washington, D.C., federal court, with an amended complaint filed November 2 and a motion for preliminary injunction filed November 4, as reported by Just The News. The lawsuit challenges the Trump administration's phaseout of "gender affirming care" coverage in 2026 and its full elimination in 2027. The plaintiffs aren't arguing the procedures worked perfectly. They're arguing they need more of them — Coe's doctors have recommended labial and vulvar tissue revision surgeries expected to cost tens of thousands of dollars.
The complaint frames the coverage removal as equivalent to "denying continuing insulin treatment for someone with diabetes." That analogy does a lot of heavy lifting when the patient's medical records read like a complication catalog.
Vanessa Voe, a War Department researcher and another class representative, declared that without continued hormone therapy, "my body suffers irreversible harm." Voe's declaration also acknowledged that stopping hormones would mean friends and colleagues "will perceive me as a different person" — and that a spouse would withdraw from the marriage. The third representative, identified as Christine F., had already undergone an orchiectomy and intended to pursue a colovaginoplasty — a procedure involving the construction of a neovagina from colon tissue — at an estimated cost of $100,000.
The medical specifics in these declarations are worth reading slowly. Coe's list of what happens when hormones stop: intrusive thoughts, mental and emotional upheaval, withdrawal symptoms, brain fog, acne, irritability, unwanted hair growth, greasier skin, and bone density loss. Every one of those symptoms is presented as evidence that coverage must continue. Not one is presented as evidence that maybe the original intervention created a permanent dependency.
The lawsuit invokes Title VII of the Civil Rights Act and the 2020 Bostock precedent on employment discrimination. Meanwhile, the Supreme Court on Monday ordered the 10th U.S. Circuit Court of Appeals to reconsider a separate case — Darlene Griffith, a male inmate challenging El Paso County, Colorado's policies — in light of its recent rulings upholding Tennessee's ban on minors' "gender affirming care" and West Virginia's ban on males in girls' sports. The legal ground is shifting under these claims faster than the plaintiffs' attorneys can file amendments.
The timing of this lawsuit lands against a backdrop the plaintiffs probably wish didn't exist. The Society for Evidence-Based Gender Medicine just held a three-day conference in D.C. featuring detransitioners and parents. Maddie Durbin, a detransitioner featured by Independent Women, is among a growing number suing their providers for lack of informed consent. A New York jury awarded $2 million to Fox Varian in a similar case. The Federal Trade Commission has opened litigation against the World Professional Association for Transgender Health — the very organization whose standards of care underpin the protocols these federal employees followed.
The people suing aren't right-wing critics. They're not religious objectors. They're not politicians scoring points. They're federal employees who did exactly what the medical establishment told them to do, used the insurance the government gave them to do it, and now have sworn declarations full of words like "irreversible," "painful," "dangerous," and "near-constant risk."
The complaint asks the court to restore coverage so the plaintiffs can get more procedures to fix the complications from the previous procedures.
The FTC is investigating the organization that wrote the guidelines. The detransitioners are suing the doctors who followed them. And the government employees who trusted the whole system are in federal court explaining what it did to their bodies.